US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist

32.210
+0.040+0.12%

Trading Nov 29 12:27 ET

2.25BMarket Cap-8521P/E (TTM)

Akero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akero Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Akero Therapeutics Earnings Reports

Akero Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 8 07:35 ET

Akero Therapeutics | 8-K: Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 8 07:25 ET

Akero Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9 07:32 ET

Akero Therapeutics | 8-K: Akero Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 9 07:17 ET

Analyst Rating

Updated: Nov 18, 2024

Strong Buy

Buy
85.71%
Hold
14.29%
Sell
0.00%

Price Target

No Data

Heat List

Overall